Human CD34+ hematopoietic cells transduced by retrovirus-mediated interferon alpha gene maintains regeneration capacity and engraftment in NOD/SCID mice

Experimental Hematology

Volumn 27, Issue 10, 1999, Pages 1511-1518

  Quan, Shuo ^a   Seiter, Karen ^a   Feldman, Eric ^a   Yang, Liming ^a   Argani, Iradge ^a   Farley, Timothy J ^a   Abraham, Nader G ^a   Ahmed, Tauseef ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

CD34+ hematopoietic cells; Immunodeficient mice; Interferon alpha; Retroviral vector

Indexed keywords

ALPHA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BURST FORMING UNIT E; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD34; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; FEMALE; GENE EXPRESSION; GENETIC VECTORS; GRANULOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON-ALPHA; MICE; MICE, INBRED NOD; MICE, SCID; RADIOIMMUNOASSAY; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0032862134     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00095-8     Document Type: Article

References (51)

1. Jaiyesimi I.A., Kantarjian H.M., Estery E.H. Advancer in therapy for hairy cell leukemia. a review Cancer. 72:1993;5.
2. Murray J.L., Macery D.J., Grant E.J., Rosenblum M.G., Kasi L.P., Zhang H.Z., Katz R.L., Riger P.T., Lebherz D., Bhadkamkar V. Enhancer TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment. Cancer Res. 55:1995;5925S.
3. Molto L., Alvarez M.M., Carballidd J., Manzano L., Gillen G., Prietd A., Olivier C., Rodriguez Z.M. Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation. Br J Cancer. 70:1994;1247.
4. Maxwell W., Mcdevitt J., Reid I., Sharpe I., Feighery C., Tanner W.A., Emmons R., Monson J. Changes in immunological parameters during interleukin 2 and interferon 2 alpha treatment of recurrent renal cell carcinoma and malignant melanoma. Eur J Surg Oncol. 19:1993;265.
5. Reiter A., Skladny H., Hochhaus A., Seifarth W., Heimpel M., Bartram C.R., Cross N.C., Hehlmann R. Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern Blot analysis. German chronic myeloid leukemia (CML) study group. Br J Haematol. 97:1997;86.
6. Talpaz M., Kantarjian H.M., Kurzrock R., Trujillo J.M., Guttermann J.U. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med. 114:1991;532.
7. Bregni M., Magni M., Siena S., Di Nicola M., Bonadonna G., Gianni A.M. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood. 80:1992;1418.
8. + bone marrow cells. Blood. 82:1993;1975.
9. + cells to protect them against alkylating agents. Hum Gene Ther. 8:1997;1901.
10. +/CD38lo human bone marrow cells reselected after long-term exposure to GALV-Pseudotyped retroviral vector. Hum Gene Ther. 8:1997;2079.
11. Haguenauer O.C., Restrepo L.M., Masset M., Bayer J., Cortivo L.D., Marolleau J.P., Benbunan M., Boiron M., Marty M. Efficient transduction of hemopoietic progenitors of human origin using an original retroviral vector derived from Fr-MuLV-FB29. in vitro assessment Hum Gene Ther. 9:1998;207.
12. Abraham N.G., Da Silva J.L., Lavrovsky Y., Stoltz R.A., Kappas A., Dunn M.W., Schwartzman M.L. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci. 36:1995;2202.
13. Chertkov J.L., Jiang S., Lutton J.D., Harrison J., Levere R.D., Tiefenthaler M., Abraham N.G. The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells. Stem Cells. 11:1993;218.
14. + cells and CML mononuclear cells. Stem Cells. 15:1997;386.
15. Cook P.C., Jiang S., Chertkov J.L., Fan Y., Levere R.D., Abraham N.G. Transfer of human adenine deaminase gene into murine hematopoietic stem cells. sequential study of spleen colony-forming units from bone marrow of living mice and the requirement of the microenvironment Acta Haematol. 96:1996;57.
16. Nolta J.A., Smogorzewska E.M., Kohn D.B. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood. 86:1995;101.
17. Moore K.A., Deisseroth A.B., Reading C.L., Williams D.E., Belmont J.W. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood. 79:1992;1393.
18. + cells from Gaucher patients. Blood. 86:1995;141.
19. Cassel A., Cottler-Fox M., Doren S., Dunbar C.E. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol. 21:1993;585.
20. Podda S., Ward M., Himelstein A., Richardson C., Flor-Weiss E.D.L., Smith L., Gottesman M., Pastan I.R., Bank A. Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci U S A. 89:1992;9676.
21. Moritz T., Patel V.P., Williams D.A. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest. 93:1994;1451.
22. Hanenberg H., Xiao X.L., Hashino K., Kato I., Williams D.A. Mechanism of high efficiency supernatant-mediated gene transfer on recombinant fibronectin fragments. Exp Hematol. 23:1995;1543.
23. Hanenberg H., Xiao X.L., Dilloo D., Hashino K., Kato I., Williams D.A. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med. 2:1996;876.
24. Dao M.A., Hashino K., Kato I., Nolta J.A. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood. 92:1998;4612.
25. Ogura H., Tani K., Ozawa K., Nagatz S., Asano S., Takaku F. Implantation of genetically manipulated fibroblasts into mice as antitumor alpha-interferon therapy. Cancer Res. 50:1990;5102.
26. Markowitz D., Goff S., Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology. 167:1988;400.
27. + marrow cells engraft lethally irradiated baboons. J Clin Invest. 81:1988;951.
28. Verfaillie C.M., Miller W.J., Boylan K., McGlave P.B. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood. 79:1992;1003.
29. Andrews R.G., Briddell R.A., Hill R., Gough M., McNiece I.K. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia. Stem Cells. 17:1999;210.
30. Cashman J.D., Lapidot T., Wang J.C.Y., Doedens M., Shultz L.D., Lansdorp P., Dick J.E., Eaves C.J. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood. 89:1997;4307.
31. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med. 330:1994;820.
32. Broxmeyer H.E., Lu L., Platzer E., Feit C., Juliano L., Rubin B.Y. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol. 131:1983;1300.
33. Geissler D., Gastl G., Aulitzky W., Tilg H., Gaggl S., Konwalinka G., Huber C. Recombinant interferon-alpha-2C in chronic myelogenous leukaemia. relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response Leuk Res. 14:1990;629.
34. Upadhyaya G., Guba S.C., Sih S.A., Feinberg A.P., Talpaz M., Kantarjian H.M., Deisseroth A.B. Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest. 88:1991;2131.
35. Dowding C., Guo A.P., Osterholz J., Siczkowski M., Goldman J., Gordon M. Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood. 78:1991;499.
36. Bhatia R., McCarthy J.B., Verfaillie C.M. Interferon-α restores normal β1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Blood. 87:1996;3883.
37. Aman M.J., Keller U., Derigs G., Mohammadzadeh M., Huber C., Peschel C. Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells. inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist Blood. 84:1994;4142.
38. Bhatia R., McGlave P.B., Verfaillie C.M., Bhatia R., Wayner E.A., McGlave P.B., Verfaillie C.M. Interferon-α restores normal adhesion of chronic myelognous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function. J Clin Invest. 94:1994;384.
39. Zoumbos N., Gascon P., Young N. The function of lymphocytes in normal and suppressed hematopoiesis. Blut. 48:1984;1.
40. Emerson S.G., Antin J.H. Bone marrow progenitor cells induce a regulatory autologous proliferative T lymphocyte response. J Immunol. 142:1989;766.
41. Ahmed T., Lutton J.D., Feldman E., Tani K., Asano S., Abraham N.G. Gene transfer of alpha interferon into hematopoietic stem cells. Leuk Res. 22:1998;119.
42. Miller D.G., Adam M.A., Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively implicating at the time of infection. Mol Cell Biol. 10:1990;4239.
43. Lapidot T., Pflumio F., Doedens M., Murdoch B., Williams D.E., Dick J.E. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science. 255:1992;1137.
44. Moritz T., Dutt P., Li X., Carstanjec D., Vik T., Hanenberg H., Williams D.A. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors. evidence of direct viral binding to chymotryptic carboxy-terminal fragments Blood. 88:1996;855.
45. + cell growth and differentiation. J Hematother. in press:1999.
46. Pflumio F., Izac B., Katz A., Shultz L.D., Vainchenker W., Coulombel L. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood. 88:1996;3731.
47. van der Loo J.C.M., Hanenberg H., Cooper R.J., Luo F.-Y., Lazaridis E.N., Williams D.A. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood. 92:1998;2556.
48. + cord blood cells. Blood. 93:1999;1097.
49. Brandt J.E., Galy A.H., Leuns K.M., Travis M., Young J., Tong J., Chen S., Davis T.A., Lee K.P., Chen B.P., Tushinski R., Hoffman R. Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line. Exp Hematol. 26:1998;950.
50. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., ByK T., Nagler A., Ben-Hur H., Many A., Schultz S., Alon R., Zipori D., Lapidot T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 283:1999;345.
51. McNience I.K. Engraftment of ex vivo-expanded cord blood cells in NOD/SCID mice. what is the clinical relevance? Blood. 93:1999;4445.